Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 5135429, 18 pages
https://doi.org/10.1155/2017/5135429
Review Article

Preclinical Studies and Translational Applications of Intracerebral Hemorrhage

1Department of Neurosurgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
2Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China

Correspondence should be addressed to Qichuan Zhuge; moc.361.piv@nauhciqeguhz and Lijie Huang; moc.361@ywgnauheijil

Received 23 February 2017; Revised 16 April 2017; Accepted 2 May 2017; Published 18 June 2017

Academic Editor: John H. Zhang

Copyright © 2017 Felix Siaw-Debrah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American heart association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar
  2. V. L. Feigin, C. M. Lawes, D. A. Bennett, S. L. Barker-Collo, and V. Parag, “Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review,” The Lancet Neurology, vol. 8, no. 4, pp. 355–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Mendelow, B. A. Gregson, H. M. Fernandes et al., “Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial,” The Lancet, vol. 365, no. 9457, pp. 387–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. Mendelow, B. A. Gregson, E. N. Rowan, G. D. Murray, A. Gholkar, and P. M. Mitchell, “Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial,” The Lancet, vol. 382, no. 9890, pp. 397–408, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Hua, R. F. Keep, J. T. Hoff, and G. Xi, “Brain injury after intracerebral hemorrhage: the role of thrombin and iron,” Stroke, vol. 38, no. 2, pp. 759–762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. M. Liu, B. Z. Shi, and J. S. Zhou, “Effects of thrombin on the secondary cerebral injury of perihematomal tissues of rats after intracerebral hemorrhage,” Genetics and Molecular Research, vol. 13, no. 2, pp. 4617–4626, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. D.-Z. Liu, B. P. Ander, H. Xu et al., “Blood-brain barrier breakdown and repair by Src after thrombin-induced injury,” Annals of Neurology, vol. 67, no. 4, pp. 526–533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Striggow, M. Riek, J. Breder, P. Henrich-Noack, K. G. Reymann, and G. Reiser, “The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 5, pp. 2264–2269, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Strbian, P. T. Kovanen, M.-L. Karjalainen-Lindsberg, T. Tatlisumak, and P. J. Lindsberg, “An emerging role of mast cells in cerebral ischemia and hemorrhage,” Annals of Medicine, vol. 41, no. 6, pp. 438–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Hua, J. Wu, R. F. Keep, T. Nakamura, J. T. Hoff, and G. Xi, “Tumor necrosis factor-α increases in the brain after intracerebral hemorrhage and thrombin stimulation,” Neurosurgery, vol. 58, no. 3, pp. 542–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wang, “Preclinical and clinical research on inflammation after intracerebral hemorrhage,” Progress in Neurobiology, vol. 92, no. 4, pp. 463–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Masada, Y. Hua, G. Xi, G.-Y. Yang, J. T. Hoff, and R. F. Keep, “Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist,” Journal of Neurosurgery, vol. 95, no. 4, pp. 680–686, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. X.-Y. Xiong, J. Wang, Z.-M. Qian, and Q.-W. Yang, “Iron and intracerebral hemorrhage: from mechanism to translation,” Translational Stroke Research, vol. 5, no. 4, pp. 429–441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Qu, W. Chen, R. Hu, and H. Feng, “The Injury and Therapy of Reactive Oxygen Species in Intracerebral Hemorrhage Looking at Mitochondria,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2592935, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Hua, G. Xi, R. F. Keep, and J. T. Hoff, “Complement activation in the brain after experimental intracerebral hemorrhage,” Journal of Neurosurgery, vol. 92, no. 6, pp. 1016–1022, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. U. K. Misra, J. Kalita, A. Vajpayee, R. V. Phadke, A. Hadique, and V. Savlani, “Effect of single mannitol bolus in intracerebral hemorrhage,” European Journal of Neurology, vol. 14, no. 10, pp. 1118–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. A. Mayer, N. C. Brun, K. Begtrup et al., “Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage,” The New England Journal of Medicine, vol. 358, no. 20, pp. 2127–2137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Fu, J. Hao, N. Zhang et al., “Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study,” JAMA Neurology, vol. 71, no. 9, pp. 1092–1101, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. P. D. Lyden, A. Shuaib, K. R. Lees et al., “Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT trial,” Stroke, vol. 38, no. 8, pp. 2262–2269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. N. R. Gonzales, J. Shah, N. Sangha et al., “Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC),” International Journal of Stroke, vol. 8, no. 5, pp. 388–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. S. Anderson, Y. Huang, H. Arima et al., “Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT),” Stroke, vol. 41, no. 2, pp. 307–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Butcher, T. Jeerakathil, D. Emery et al., “The intracerebral haemorrhage acutely decreasing arterial pressure trial: ICH ADAPT,” International Journal of Stroke, vol. 5, no. 3, pp. 227–233, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. I. Qureshi, Y. Y. Palesch, R. Martin et al., “Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study,” Archives of Neurology, vol. 67, no. 5, pp. 570–576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Sharma, H. Sane, N. Gokulchandran et al., “Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke,” Stroke Research and Treatment, vol. 2014, Article ID 234095, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. J. P. Broderick, T. G. Brott, T. Tomsick, W. Barsan, and J. Spilker, “Ultra-early evaluation of intracerebral hemorrhage,” Journal of Neurosurgery, vol. 72, no. 2, pp. 195–199, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. S. M. Davis, J. Broderick, M. Hennerici et al., “Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage,” Neurology, vol. 66, no. 8, pp. 1175–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Steiner, M. N. Diringer, D. Schneider et al., “Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII,” Neurosurgery, vol. 59, no. 4, pp. 767–773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Fujii, R. Tanaka, S. Takeuchi, T. Koike, T. Minakawa, and O. Sasaki, “Hematoma enlargement in spontaneous intracerebral hemorrhage,” Journal of Neurosurgery, vol. 80, no. 1, pp. 51–57, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Xi, R. F. Keep, and J. T. Hoff, “Pathophysiology of brain edema formation,” Neurosurgery Clinics of North America, vol. 13, no. 3, pp. 371–383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. J. T. Hoff and G. Xi, “Brain edema from intracerebral hemorrhage,” Acta Neurochirurgica, Supplementum, no. 86, pp. 11–15, 2003. View at Google Scholar · View at Scopus
  31. K. Sinha, J. Das, P. B. Pal, and P. C. Sil, “Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis,” Archives of Toxicology, vol. 87, no. 7, pp. 1157–1180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Hu, C. Tao, Q. Gan, J. Zheng, H. Li, and C. You, “Oxidative stress in intracerebral hemorrhage: sources, mechanisms, and therapeutic targets,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3215391, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Sun, A. Peacock, J. Becker, B. Phillips-Bute, D. T. Laskowitz, and M. L. James, “Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage,” Journal of Clinical Neuroscience, vol. 19, no. 8, pp. 1096–1100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Pozzilli, G. L. Lenzi, C. Argentino et al., “Imaging of leukocytic infiltration in human cerebral infarcts,” Stroke, vol. 16, no. 2, pp. 251–255, 1985. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Wu, Y. Cong, D. Wang, R. Zhao, and J. Qi, “Correlation of macrophage inflammatory protein-2 expression and brain edema in rats after intracerebral hemorrhage,” International Journal of Clinical and Experimental Pathology, vol. 2, no. 1, pp. 83–90, 2009. View at Google Scholar · View at Scopus
  36. S. Yang, S. Song, Y. Hua, T. Nakamura, R. F. Keep, and G. Xi, “Effects of thrombin on neurogenesis after intracerebral hemorrhage,” Stroke, vol. 39, no. 7, pp. 2079–2084, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Xi, J. Strahle, Y. Hua, and R. F. Keep, “Progress in translational research on intracerebral hemorrhage: is there an end in sight?” Progress in neurobiology, vol. 115, pp. 45–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. G. A. Rosenberg, S. Mun-Bryce, M. Wesley, and M. Komfeld, “Collagenase-induced intracerebral hemorrhage in rats,” Stroke, vol. 21, no. 5, pp. 801–807, 1990. View at Publisher · View at Google Scholar · View at Scopus
  39. G. A. Rosenberg, E. Estrada, R. O. Kelley, and M. Kornfeld, “Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat,” Neuroscience Letters, vol. 160, no. 1, pp. 117–119, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. M. A. Kirkman, S. M. Allan, and A. R. Parry-Jones, “Experimental intracerebral hemorrhage: avoiding pitfalls in translational research,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 11, pp. 2135–2151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Xue and M. R. Del Bigio, “Intracerebral injection of autologous whole blood in rats: Time course of inflammation and cell death,” Neuroscience Letters, vol. 283, no. 3, pp. 230–232, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. M. R. Del Bigio, H.-J. Yan, R. Buist, and J. Peeling, “Experimental intracerebral hemorrhage in rats: Magnetic resonance imaging and histopathological correlates,” Stroke, vol. 27, no. 12, pp. 2312–2320, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. Q. Ma, B. Huang, N. Khatibi et al., “PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage,” Annals of Neurology, vol. 70, no. 6, pp. 920–931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Lei, H. Sheng, H. Wang et al., “Intrastriatal injection of autologous blood or clostridial collagenase as murine models of intracerebral hemorrhage,” Journal of Visualized Experiments, no. 89, Article ID e51439, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. T. A. Kingman, A. D. Mendelow, D. I. Graham, and G. M. Teasdale, “Experimental intracerebral mass: description of model, intracranial pressure changes and neuropathology,” Journal of Neuropathology and Experimental Neurology, vol. 47, no. 2, pp. 128–137, 1988. View at Publisher · View at Google Scholar · View at Scopus
  46. E. J. Sinar, A. D. Mendelow, D. I. Graham, and G. M. Teasdale, “Experimental intracerebral hemorrhage: effects of a temporary mass lesion,” Journal of Neurosurgery, vol. 66, no. 4, pp. 568–576, 1987. View at Publisher · View at Google Scholar · View at Scopus
  47. Q. Ma, N. H. Khatibi, H. Chen, J. Tang, and J. H. Zhang, “History of preclinical models of intracerebral hemorrhage,” Acta Neurochirurgica, Supplementum, no. 111, pp. 3–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. B. B. Aggarwal, C. Sundaram, N. Malani, and H. Ichikawa, “Curcumin: the Indian solid gold,” Advances in Experimental Medicine and Biology, vol. 595, pp. 1–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal, “Multiple biological activities of curcumin: a short review,” Life Sciences, vol. 78, no. 18, pp. 2081–2087, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Fu and R. Kurzrock, “Development of curcumin as an epigenetic agent,” Cancer, vol. 116, no. 20, pp. 4670–4676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. D. King, D. J. McCracken, F. M. Wade, S. E. Meiler, C. H. Alleyne Jr., and K. M. Dhandapani, “Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice: laboratory investigation,” Journal of Neurosurgery, vol. 115, no. 1, pp. 116–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Yuan, W. Liu, H. Zhu et al., “Curcumin attenuates blood-brain barrier disruption after subarachnoid hemorrhage in mice,” Journal of Surgical Research, vol. 207, pp. 85–91, 2017. View at Publisher · View at Google Scholar
  53. Y. Sun, M. Dai, Y. Wang et al., “Neuroprotection and sensorimotor functional improvement by curcumin after intracerebral hemorrhage in mice,” Journal of Neurotrauma, vol. 28, no. 12, pp. 2513–2521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. W. Liu, J. Yuan, H. Zhu et al., “Curcumin reduces brain-infiltrating T lymphocytes after intracerebral hemorrhage in mice,” Neuroscience Letters, vol. 620, pp. 74–82, 2016. View at Publisher · View at Google Scholar · View at Scopus
  55. Z. Qiu and S. Yue, “Curcumin improves learning and memory function through decreasing hippocampal TNF-α and iNOS levels after subarachnoid hemorrhage in rats,” Chinese Journal of Cellular And Molecular Immunology, vol. 32, no. 3, pp. 343–346, 2016. View at Google Scholar · View at Scopus
  56. E.-E. Baulieu and P. Robel, “Neurosteroids: a new brain function?” Journal of Steroid Biochemistry and Molecular Biology, vol. 37, no. 3, pp. 395–403, 1990. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Jiang, F. Zuo, Y. Wang et al., “Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after intracerebral hemorrhage in middle-aged mice,” Neurobiology of Aging, vol. 42, pp. 13–24, 2016. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Lei, H. Wang, S. Jeong et al., “Progesterone improves neurobehavioral outcome in models of intracerebral hemorrhage,” Neuroendocrinology, vol. 103, no. 6, pp. 665–677, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. A. F. De Nicola, F. Labombarda, M. C. G. Deniselle et al., “Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 173–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. R. Corti, A. J. Flammer, N. K. Hollenberg, and T. F. Luscher, “Cocoa and cardiovascular health,” Circulation, vol. 119, no. 10, pp. 1433–1441, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. X. Lan, X. Han, Q. Li, and J. Wang, “(−)-epicatechin, a natural flavonoid compound, protects astrocytes against hemoglobin toxicity via Nrf2 and AP-1 signaling pathways,” Molecular Neurobiology, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  62. J.-M. Lee, J. Li, D. A. Johnson et al., “Nrf2, a multi-organ protector?” The FASEB Journal, vol. 19, no. 9, pp. 1061–1066, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. J.-M. Lee and J. A. Johnson, “An important role of Nrf2-ARE pathway in the cellular defense mechanism,” Journal of Biochemistry and Molecular Biology, vol. 37, no. 2, pp. 139–143, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Zhang, X. Chen, H. Song, H.-Z. Chen, and B. H. Rovin, “Activation of the Nrf2/antioxidant response pathway increases IL-8 expression,” European Journal of Immunology, vol. 35, no. 11, pp. 3258–3267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Cheng, W. Wang, Q. Li et al., “Cerebroprotection of flavanol (−)-epicatechin after traumatic brain injury via Nrf2-dependent and -independent pathways,” Free Radical Biology and Medicine, vol. 92, pp. 15–28, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Medeiros, C. Peres-Buzalaf, F. Fortino Verdan, and C. H. Serezani, “Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs,” Mediators of Inflammation, vol. 2012, Article ID 327568, 13 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Zhao, T. Wu, C.-F. Chang et al., “Toxic role of prostaglandin E2 receptor EP1 after intracerebral hemorrhage in mice,” Brain, Behavior, and Immunity, vol. 46, pp. 293–310, 2015. View at Publisher · View at Google Scholar · View at Scopus
  68. D.-Z. Liu and F. R. Sharp, “The dual role of src kinases in intracerebral hemorrhage,” Acta Neurochirurgica, Supplementum, no. 111, pp. 77–81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. N. J. Abbott, “Astrocyte-endothelial interactions and blood-brain barrier permeability,” Journal of Anatomy, vol. 200, no. 6, pp. 629–638, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Persidsky, S. H. Ramirez, J. Haorah, and G. D. Kanmogne, “Blood-brain barrier: structural components and function under physiologic and pathologic conditions,” Journal of Neuroimmune Pharmacology, vol. 1, no. 3, pp. 223–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Taniguchi, C. Anacker, G. B. Suarez-Mier, Q. Wang, and K. Andreasson, “Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy,” Neuroscience Letters, vol. 504, no. 3, pp. 185–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Wu, T. Wu, W. Hua et al., “PGE2 receptor agonist misoprostol protects brain against intracerebral hemorrhage in mice,” Neurobiology of Aging, vol. 36, no. 3, pp. 1439–1450, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Naseem and S. Parvez, “Role of melatonin in traumatic brain injury and spinal cord injury,” Scientific World Journal, vol. 2014, Article ID 586270, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. Y.-C. Hung, T.-Y. Chen, E.-J. Lee et al., “Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats,” Journal of Pineal Research, vol. 45, no. 4, pp. 459–467, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Lekic, R. Hartman, H. Rojas et al., “Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats,” Journal of Neurotrauma, vol. 27, no. 3, pp. 627–637, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Rojas, T. Lekic, W. Chen et al., “The antioxidant effects of melatonin after intracerebral hemorrhage in rats,” Acta Neurochirurgica, Supplementum, no. 105, pp. 19–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Ueda, T. Masuda, A. Ishida et al., “Enhanced electrical responsiveness in the cerebral cortex with oral melatonin administration after a small hemorrhage near the internal capsule in rats,” Journal of Neuroscience Research, vol. 92, no. 11, pp. 1499–1508, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Yang, A. Manaenko, F. Xu et al., “Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model,” Experimental Neurology, vol. 283, pp. 157–164, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. W. J. Pearce, C. Doan, D. Carreon et al., “Imatinib attenuates cerebrovascular injury and phenotypic transformation after intracerebral hemorrhage in rats,” American Journal of Physiology—Regulatory, Integrative and Comparative Physiology, vol. 311, no. 6, pp. R1093–R1104, 2016. View at Publisher · View at Google Scholar
  80. M. Shiba, H. Suzuki, M. Fujimoto et al., “Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats,” Neurobiology of Disease, vol. 46, no. 1, pp. 172–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Kong and Y. Le, “Toll-like receptors in inflammation of the central nervous system,” International Immunopharmacology, vol. 11, no. 10, pp. 1407–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Aderem and R. J. Ulevitch, “Toll-like receptors in the induction of the innate immune response,” Nature, vol. 406, no. 6797, pp. 782–787, 2000. View at Publisher · View at Google Scholar · View at Scopus
  83. L. H. Sansing, T. H. Harris, F. A. Welsh, S. E. Kasner, C. A. Hunter, and K. Kariko, “Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage,” Annals of Neurology, vol. 70, no. 4, pp. 646–656, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. Q. Liang, Q. Wu, J. Jiang et al., “Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties,” The Journal of Biological Chemistry, vol. 286, no. 30, pp. 26470–26479, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. Q. Zhong, K. Zhou, Q. Liang et al., “Interleukin‐23 secreted by activated macrophages drives γδT cell production of interleukin‐17 to aggravate secondary injury after intracerebral hemorrhage,” Journal of the American Heart Association, vol. 5, no. 10, Article ID e004340, 2016. View at Publisher · View at Google Scholar
  86. S. Holmin and T. Mathiesen, “Dexamethasone and colchicine reduce inflammation and delayed oedema following experimental brain contusion,” Acta Neurochirurgica, vol. 138, no. 4, pp. 418–424, 1996. View at Publisher · View at Google Scholar · View at Scopus
  87. I.-N. Lee, W.-C. Cheng, C.-Y. Chung et al., “Dexamethasone reduces brain cell apoptosis and inhibits inflammatory response in rats with intracerebral hemorrhage,” Journal of Neuroscience Research, vol. 93, no. 1, pp. 178–188, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. J.-T. Yang, T.-H. Lee, I.-N. Lee, C.-Y. Chung, C.-H. Kuo, and H.-H. Weng, “Dexamethasone inhibits ICAM-1 and MMP-9 expression and reduces brain edema in intracerebral hemorrhagic rats,” Acta Neurochirurgica, vol. 153, no. 11, pp. 2197–2203, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. P. Vachon and J.-P. Moreau, “Low doses of dexamethasone decrease brain water content of collagenase-induced cerebral hematoma,” Canadian Journal of Veterinary Research, vol. 67, no. 2, pp. 157–159, 2003. View at Google Scholar · View at Scopus
  90. B.-B. Gao, A. Clermont, S. Rook et al., “Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation,” Nature Medicine, vol. 13, no. 2, pp. 181–188, 2007. View at Publisher · View at Google Scholar · View at Scopus
  91. H. Fujisawa, H. Ito, S. Kashiwagi, S. Nomura, and M. Toyosawa, “Kallikrein-kinin system in chronic subdural haematomas: its roles in vascular permeability and regulation of fibrinolysis and coagulation,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 59, no. 4, pp. 388–394, 1995. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Liu, B.-B. Gao, A. C. Clermont et al., “Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein,” Nature Medicine, vol. 17, no. 2, pp. 206–211, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. F. Simão, T. Ustunkaya, A. C. Clermont, and E. P. Feener, “Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke,” Blood, vol. 129, no. 16, pp. 2280–2290, 2017. View at Publisher · View at Google Scholar
  94. H. Apeler, J. Peters, W. Schröder et al., “Expression, purification, biochemical and pharmacological characterization of a recombinant aprotinin variant,” Arzneimittel-Forschung/Drug Research, vol. 54, no. 8, pp. 483–497, 2004. View at Google Scholar · View at Scopus
  95. A. Ghosh, S. Sarkar, A. K. Mandal, and N. Das, “Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats,” PLoS ONE, vol. 8, no. 4, Article ID e57735, 2013. View at Publisher · View at Google Scholar · View at Scopus
  96. A. R. Galho, M. F. Cordeiro, S. A. Ribeiro et al., “Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in rats,” Nanotechnology, vol. 27, no. 17, Article ID 175101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  97. L. Y.-H. Sang, Y.-X. Liang, Y. Li et al., “A self-assembling nanomaterial reduces acute brain injury and enhances functional recovery in a rat model of intracerebral hemorrhage,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 11, no. 3, pp. 611–620, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. O. S. Elizarova, S. A. Litvinova, V. Y. Balabanyan et al., “Neuroprotective effect of recombinant human erythropoietin-loaded poly(lactic-co-glycolic) acid nanoparticles in rats with intracerebral posttraumatic hematoma,” Eksperimental'naya i Klinicheskaya Farmakologiya, vol. 75, no. 8, pp. 7–10, 2012. View at Google Scholar · View at Scopus
  99. V. Y. Balaban'ian, I. N. Solev, O. S. Elizarova, T. L. Garibova, S. A. Litvinova, and T. A. Voronina, “Neuroprotector effect of human recombinant erythropoietin sorbed on polymer nanoparticles studied on model of intracerebral post-traumatic hematoma (hemorrhagic stroke),” Eksperimental'naya i Klinicheskaya Farmakologiya, vol. 74, no. 10, pp. 17–22, 2011. View at Google Scholar · View at Scopus
  100. G. E. Goings, V. Sahni, and F. G. Szele, “Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury,” Brain Research, vol. 996, no. 2, pp. 213–226, 2004. View at Publisher · View at Google Scholar · View at Scopus
  101. J. M. Parent, Z. S. Vexler, C. Gong, N. Derugin, and D. M. Ferriero, “Rat forebrain neurogenesis and striatal neuron replacement after focal stroke,” Annals of Neurology, vol. 52, no. 6, pp. 802–813, 2002. View at Publisher · View at Google Scholar · View at Scopus
  102. N. M. Walton, B. M. Sutter, E. D. Laywell et al., “Microglia instruct subventricular zone neurogenesis,” Glia, vol. 54, no. 8, pp. 815–825, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. Y. Ziv, N. Ron, O. Butovsky et al., “Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood,” Nature Neuroscience, vol. 9, no. 2, pp. 268–275, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. J. V. Welser, L. Li, and R. Milner, “Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1,” Journal of Neuroinflammation, vol. 7, article 89, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Kobayashi, H. Ahlenius, P. Thored, R. Kobayashi, Z. Kokaia, and O. Lindvall, “Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats,” Stroke, vol. 37, no. 9, pp. 2361–2367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. R. J. Dempsey, K. A. Sailor, K. K. Bowen, K. Türeyen, and R. Vemuganti, “Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF,” Journal of Neurochemistry, vol. 87, no. 3, pp. 586–597, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp, “Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats,” Stroke, vol. 35, no. 7, pp. 1732–1737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  108. B. D. Hoehn, T. D. Palmer, and G. K. Steinberg, “Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin,” Stroke, vol. 36, no. 12, pp. 2718–2724, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. Y.-P. Yan, K. A. Sailor, B. T. Lang, S.-W. Park, R. Vemuganti, and R. J. Dempsey, “Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 6, pp. 1213–1224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. H.-J. Zhou, T. Tang, H.-J. Cui et al., “Thrombin-triggered angiogenesis in rat brains following experimental intracerebral hemorrhage,” Journal of Neurosurgery, vol. 117, no. 5, pp. 920–928, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. P. Koch, T. Opitz, J. A. Steinbeck, J. Ladewig, and O. Brüstle, “A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 9, pp. 3225–3230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. P. Stroemer, A. Hope, S. Patel, K. Pollock, and J. Sinden, “Development of a human neural stem cell line for use in recovery from disability after stroke,” Frontiers in Bioscience, vol. 13, no. 6, pp. 2290–2292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. A. Hicks and J. Jolkkonen, “Challenges and possibilities of intravascular cell therapy in stroke,” Acta Neurobiologiae Experimentalis, vol. 69, no. 1, pp. 1–11, 2009. View at Google Scholar · View at Scopus
  114. T. Wakai, H. Sakata, P. Narasimhan, H. Yoshioka, H. Kinouchi, and P. H. Chan, “Transplantation of neural stem cells that overexpress SOD1 enhances amelioration of intracerebral hemorrhage in mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 34, no. 3, pp. 441–449, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. S. Jeong, K. Chu, K. Jung, S. U. Kim, M. Kim, and J. Roh, “Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage,” Stroke, vol. 34, no. 9, pp. 2258–2263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  116. L. Gao, Q. Lu, L.-J. Huang et al., “Transplanted neural stem cells modulate regulatory T, γδ T cells and corresponding cytokines after intracerebral hemorrhage in rats,” International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4431–4441, 2014. View at Publisher · View at Google Scholar · View at Scopus
  117. M. Chen, X. Li, X. Zhang et al., “The inhibitory effect of mesenchymal stem cell on blood-brain barrier disruption following intracerebral hemorrhage in rats: contribution of TSG-6,” Journal of Neuroinflammation, vol. 12, no. 1, article 61, 2015. View at Publisher · View at Google Scholar · View at Scopus
  118. N. Shimamura, K. Kakuta, L. Wang et al., “Neuro-regeneration therapy using human muse cells is highly effective in a mouse intracerebral hemorrhage model,” Experimental Brain Research, vol. 235, no. 2, pp. 565–572, 2017. View at Publisher · View at Google Scholar
  119. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  120. M. Pereira, U. Pfisterer, D. Rylander et al., “Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain,” Scientific Reports, vol. 4, article 6330, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. S. M. Chambers, C. A. Fasano, E. P. Papapetrou, M. Tomishima, M. Sadelain, and L. Studer, “Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling,” Nature Biotechnology, vol. 27, no. 3, pp. 275–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. S. Y. Ahn, Y. S. Chang, D. K. Sung et al., “Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage,” Stroke, vol. 44, no. 2, pp. 497–504, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. H. Arima, J. G. Wang, Y. Huang et al., “Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial,” Neurology, vol. 73, no. 23, pp. 1963–1968, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. K. R. Wagner, G. Xi, Y. Hua et al., “Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter,” Stroke, vol. 27, no. 3, pp. 490–497, 1996. View at Publisher · View at Google Scholar · View at Scopus
  125. X. Wang, H. Arima, J. Yang et al., “Mannitol and outcome in intracerebral hemorrhage: propensity score and multivariable intensive blood pressure reduction in acute cerebral hemorrhage trial 2 results,” Stroke, vol. 46, no. 10, pp. 2762–2767, 2015. View at Publisher · View at Google Scholar · View at Scopus
  126. A. I. Qureshi, M. F. K. Suri, A. J. Ringer, L. R. Guterman, and L. N. Hopkins, “Regional intraparenchymal pressure differences in experimental intracerebral hemorrhage: effect of hypertonic saline,” Critical Care Medicine, vol. 30, no. 2, pp. 435–441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  127. A. I. Qureshi, D. A. Wilson, and R. J. Traystman, “Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism,” Journal of Neurosurgical Anesthesiology, vol. 14, no. 1, pp. 22–30, 2002. View at Publisher · View at Google Scholar · View at Scopus
  128. M. A. Koenig, M. Bryan, J. L. Lewin III, M. A. Mirski, R. G. Geocadin, and R. D. Stevens, “Reversal of transtentorial herniation with hypertonic saline,” Neurology, vol. 70, no. 13, pp. 1023–1029, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. I. Wagner, E.-M. Hauer, D. Staykov et al., “Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution,” Stroke, vol. 42, no. 6, pp. 1540–1545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  130. M. H. Askenase and L. H. Sansing, “Stages of the inflammatory response in pathology and tissue repair after intracerebral hemorrhage,” Seminars in Neurology, vol. 36, no. 3, pp. 288–297, 2016. View at Publisher · View at Google Scholar · View at Scopus
  131. Y. Zhou, Y. Wang, J. Wang, R. Anne Stetler, and Q.-W. Yang, “Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation,” Progress in Neurobiology, vol. 115, pp. 25–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. K. Chu, S.-W. Jeong, K.-H. Jung et al., “Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 8, pp. 926–933, 2004. View at Google Scholar · View at Scopus
  133. H.-K. Park, S.-H. Lee, K. Chu, and J.-K. Roh, “Effects of celecoxib on volumes of hematoma and edema in patients with primary intracerebral hemorrhage,” Journal of the Neurological Sciences, vol. 279, no. 1-2, pp. 43–46, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. S.-H. Lee, H.-K. Park, W.-S. Ryu et al., “Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial,” European Journal of Neurology, vol. 20, no. 8, pp. 1161–1169, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. F. Schlunk, W. Pfeilschifter, K. Yigitkanli, E. H. Lo, and C. Foerch, “Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage,” Experimental and Translational Stroke Medicine, vol. 8, no. 1, article 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  136. L. Lu, A. H. Barfejani, T. Qin, Q. Dong, C. Ayata, and C. Waeber, “Fingolimod exerts neuroprotective effects in a mouse model of intracerebral hemorrhage,” Brain Research, vol. 1555, pp. 89–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  137. W. B. Rolland, T. Lekic, P. R. Krafft et al., “Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage,” Experimental Neurology, vol. 241, no. 1, pp. 45–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. N. Sun, Y. Shen, W. Han et al., “Selective sphingosine-1-phosphate receptor 1 modulation attenuates experimental intracerebral hemorrhage,” Stroke, vol. 47, no. 7, pp. 1899–1906, 2016. View at Publisher · View at Google Scholar · View at Scopus
  139. H. E. Williams, M. Claybourn, and A. R. Green, “Investigating the free radical trapping ability of NXY-059, S-PBN and PBN,” Free Radical Research, vol. 41, no. 9, pp. 1047–1052, 2007. View at Publisher · View at Google Scholar · View at Scopus
  140. K. Hensley, J. M. Carney, C. A. Stewart, T. Tabatabaie, Q. Pye, and R. A. Floyd, “Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies.,” International review of neurobiology, vol. 40, pp. 299–317, 1997. View at Google Scholar · View at Scopus
  141. S. G. Sydserff, A. R. Borelli, A. R. Green, and A. J. Cross, “Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window,” British Journal of Pharmacology, vol. 135, no. 1, pp. 103–112, 2002. View at Publisher · View at Google Scholar · View at Scopus
  142. P. A. Lapchak, D. M. Araujo, D. Song, J. Wei, R. Purdy, and J. A. Zivin, “Effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model: Combination studies with tissue plasminogen activator,” Stroke, vol. 33, no. 6, pp. 1665–1670, 2002. View at Publisher · View at Google Scholar · View at Scopus
  143. P. A. Lapchak, D. M. Araujo, D. Song, J. Wei, and J. A. Zivin, “Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator,” Stroke, vol. 33, no. 5, pp. 1411–1415, 2002. View at Publisher · View at Google Scholar · View at Scopus
  144. J. Peeling, M. R. Del Bigio, D. Corbett, A. R. Green, and D. M. Jackson, “Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke,” Neuropharmacology, vol. 40, no. 3, pp. 433–439, 2001. View at Publisher · View at Google Scholar · View at Scopus
  145. S. Strid, O. Borgå, C. Edenius, K.-G. Jostell, T. Odergren, and A. Weil, “Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke,” European Journal of Clinical Pharmacology, vol. 58, no. 6, pp. 409–415, 2002. View at Publisher · View at Google Scholar · View at Scopus
  146. Y. Hua, R. F. Keep, J. T. Hoff, and G. Xi, “Deferoxamine therapy for intracerebral hemorrhage,” Acta Neurochirurgica, Supplementum, vol. 105, pp. 3–6, 2008. View at Google Scholar
  147. Y. Hua, T. Nakamura, R. F. Keep et al., “Long-term effects of experimental intracerebral hemorrhage: the role of iron,” Journal of Neurosurgery, vol. 104, no. 2, pp. 305–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  148. T. Hatakeyama, M. Okauchi, Y. Hua, R. F. Keep, and G. Xi, “Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats,” Translational Stroke Research, vol. 4, no. 5, pp. 546–553, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. T. Hatakeyama, M. Okauchi, Y. Hua, R. F. Keep, and G. Xi, “Deferoxamine reduces cavity size in the brain after intracerebral hemorrhage in aged rats,” in Intracerebral Hemorrhage Research, vol. 111 of Acta Neurochirurgica Supplementum, pp. 185–190, Springer, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Selim, S. Yeatts, J. N. Goldstein et al., “Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage,” Stroke, vol. 42, no. 11, pp. 3067–3074, 2011. View at Publisher · View at Google Scholar · View at Scopus
  151. E. Simpson, Y. Lin, S. Stanworth, J. Birchall, C. Doree, and C. Hyde, “Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.,” Cochrane Database of Systematic Reviews, Article ID CD005011, 2011. View at Google Scholar
  152. S. A. Mayer, N. C. Brun, K. Begtrup et al., “Recombinant activated factor VII for acute intracerebral hemorrhage,” New England Journal of Medicine, vol. 352, no. 8, pp. 777–851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  153. A. Lauer, F. Schlunk, E. M. Van Cott, H. Steinmetz, E. H. Lo, and C. Foerch, “Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 8, pp. 1736–1742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  154. T. Okada, T. Nakase, M. Sasaki, and T. Ishikawa, “Do the antithrombotic therapy at the time of intracerebral hemorrhage influence clinical outcome? analysis between the difference of antiplatelet and anticoagulant agents and clinical course,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 7, pp. 1781–1788, 2014. View at Publisher · View at Google Scholar · View at Scopus
  155. P. G. Campbell, S. Yadla, A. N. Sen, J. Jallo, and P. Jabbour, “Emergency reversal of clopidogrel in the setting of spontaneous intracerebral hemorrhage,” World Neurosurgery, vol. 76, no. 1-2, pp. 100–104, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. M. I. Baharoglu, C. Cordonnier, R. A.-S. Salman et al., “Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial,” The Lancet, vol. 387, no. 10038, pp. 2605–2613, 2016. View at Publisher · View at Google Scholar · View at Scopus
  157. J. A. Frontera, J. J. Lewin III, A. A. Rabinstein et al., “Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical Care Medicine,” Neurocritical Care, vol. 24, no. 1, pp. 6–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  158. A. I. Qureshi, “Acute hypertensive response in patients with stroke pathophysiology and management,” Circulation, vol. 118, no. 2, pp. 176–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  159. Y.-H. Sang, H.-X. Su, W.-T. Wu, K.-F. So, and R. T.-F. Cheung, “Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury,” Journal of Neurotrauma, vol. 28, no. 12, pp. 2523–2534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  160. L. H. Sansing, S. R. Messe, B. L. Cucchiara, P. D. Lyden, and S. E. Kasner, “Anti-adrenergic medications and edema development after intracerebral hemorrhage,” Neurocritical Care, vol. 14, no. 3, pp. 395–400, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. J. Kalita, U. K. Misra, and B. Kumar, “Is beta-blocker (atenolol) a preferred antihypertensive in acute intracerebral hemorrhage?” Neurological Sciences, vol. 34, no. 7, pp. 1099–1104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  162. J. P. Shoup, J. Winkler, A. Czap et al., “β-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage,” Journal of the Neurological Sciences, vol. 336, no. 1-2, pp. 127–131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  163. V. Bocher, G. Chinetti, J.-C. Fruchart, and B. Staels, “Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control,” Journal de la Societe de biologie, vol. 196, no. 1, pp. 47–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  164. J. Berger and D. E. Moller, “The mechanisms of action of PPARs,” Annual Review of Medicine, vol. 53, pp. 409–435, 2002. View at Publisher · View at Google Scholar · View at Scopus
  165. X. Zhao, J. Grotta, N. Gonzales, and J. Aronowski, “Hematoma resolution as a therapeutic target: the role of microglia/macrophages,” Stroke, vol. 40, no. 3, pp. S92–S94, 2009. View at Publisher · View at Google Scholar · View at Scopus
  166. X. Zhao, G. Sun, J. Zhang et al., “Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages,” Annals of Neurology, vol. 61, no. 4, pp. 352–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  167. P. Delerive, J. C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors in inflammation control,” Journal of Endocrinology, vol. 169, no. 3, pp. 453–459, 2001. View at Publisher · View at Google Scholar · View at Scopus
  168. X. Zhao, Y. Zhang, R. Strong, J. C. Grotta, and J. Aronowski, “15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-γ, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 6, pp. 811–820, 2006. View at Publisher · View at Google Scholar · View at Scopus
  169. T. M. Bliss, R. H. Andres, and G. K. Steinberg, “Optimizing the success of cell transplantation therapy for stroke,” Neurobiology of Disease, vol. 37, no. 2, pp. 275–283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  170. D. Kondziolka, G. K. Steinberg, L. Wechsler et al., “Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial,” Journal of Neurosurgery, vol. 103, no. 1, pp. 38–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. C. Suarez-Monteagudo, P. Hernandez-Ramirez, L. Alvarez-Gonzalez, I. Garcia-Maeso, K. de la Cuetara-Bernal, L. Castillo-Diaz et al., “Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study,” Restorative Neurology And Neuroscience, vol. 27, pp. 151–161, 2009. View at Google Scholar
  172. Z.-M. Li, Z.-T. Zhang, C.-J. Guo, F.-Y. Geng, F. Qiang, and L.-X. Wang, “Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage—a prospective clinical observation,” Clinical Neurology and Neurosurgery, vol. 115, no. 1, pp. 72–76, 2013. View at Publisher · View at Google Scholar · View at Scopus
  173. A. Bhasin, M. V. Srivastava, and S. S. Kumaran, “Autologous mesenchymal stem cells in chronic stroke,” Cerebrovascular Diseases Extra, vol. 1, no. 1, pp. 93–104, 2011. View at Publisher · View at Google Scholar
  174. J. Zhu, Y. Xiao, Z. Li et al., “Efficacy of surgery combined with autologous bone marrow stromal cell transplantation for treatment of intracerebral hemorrhage,” Stem Cells International, vol. 2015, Article ID 318269, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  175. K. Hase, E. Suzuki, M. Matsumoto, T. Fujiwara, and M. Liu, “Effects of therapeutic gait training using a prosthesis and a treadmill for ambulatory patients with hemiparesis,” Archives of Physical Medicine and Rehabilitation, vol. 92, no. 12, pp. 1961–1966, 2011. View at Publisher · View at Google Scholar · View at Scopus
  176. A. F. Bailes, C. Caldwell, M. Clay, M. Tremper, K. Dunning, and J. Long, “An exploratory study of gait and functional outcomes after neuroprosthesis use in children with hemiplegic cerebral palsy,” Disability and Rehabilitation, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  177. S. Masiero, A. Celia, G. Rosati, and M. Armani, “Robotic-assisted rehabilitation of the upper limb after acute stroke,” Archives of Physical Medicine and Rehabilitation, vol. 88, no. 2, pp. 142–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  178. J. Mehrholz, M. Pohl, T. Platz, J. Kugler, and B. Elsner, “Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke,” Cochrane Database of Systematic Reviews, Article ID CD006876, 2015. View at Google Scholar
  179. B. T. Volpe, H. I. Krebs, N. Hogan, L. Edelstein, C. Diels, and M. Aisen, “A novel approach to stroke rehabilitation: robot-aided sensorimotor stimulation,” Neurology, vol. 54, no. 10, pp. 1938–1944, 2000. View at Publisher · View at Google Scholar · View at Scopus
  180. N. Birbaumer, N. Ghanayim, T. Hinterberger et al., “A spelling device for the paralysed,” Nature, vol. 398, no. 6725, pp. 297-298, 1999. View at Publisher · View at Google Scholar · View at Scopus
  181. D. Santana, M. Ramirez, and F. Ostrosky-Solis, “Recent advances in rehabilitation technology: a review of the brain-computer interface,” Revista de Neurologia, vol. 39, pp. 447–450, 2004. View at Google Scholar
  182. A. Kübler and N. Neumann, “Brain-computer interfaces—The key for the conscious brain locked into a paralyzed body,” Progress in Brain Research, vol. 150, pp. 513–525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. E. W. Sellers, D. B. Ryan, and C. K. Hauser, “Noninvasive brain-computer interface enables communication after brainstem stroke,” Science Translational Medicine, vol. 6, no. 257, Article ID 257re7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  184. G. Q. Zheng and P. X. Huang, “Origin and development of hemorrhagic stroke,” Zhonghua yi shi za zhi, vol. 35, pp. 25–28, 2005. View at Google Scholar
  185. B. Wu, M. Liu, H. Liu et al., “Meta-analysis of traditional Chinese patent medicine for ischemic stroke,” Stroke, vol. 38, no. 6, pp. 1973–1979, 2007. View at Publisher · View at Google Scholar · View at Scopus
  186. Y. Z. Zhao and C. D. Yu, “Effect of cranial needling combined with medicine on IL-6 in the patient of acute cerebral hemorrhage,” Chinese Acupuncture & Moxibustion, vol. 28, pp. 569–572, 2008. View at Google Scholar
  187. X.-D. Wu, L.-N. Du, G.-C. Wu, and X.-D. Cao, “Effects of electroacupuncture on blood-brain barrier after cerebral ischemia-reperfusion in rat,” Acupuncture and Electro-Therapeutics Research, vol. 26, no. 1-2, pp. 1–9, 2001. View at Publisher · View at Google Scholar · View at Scopus
  188. S. Zhong, Z. Li, L. Huan, and B.-Y. Chen, “Neurochemical mechanism of electroacupuncture: anti-injury effect on cerebral function after focal cerebral ischemia in rats,” Evidence-based Complementary and Alternative Medicine, vol. 6, no. 1, pp. 51–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  189. F. Zhou, J. Guo, J. Cheng, G. Wu, and Y. Xia, “Electroacupuncture increased cerebral blood flow and reduced ischemic brain injury: dependence on stimulation intensity and frequency,” Journal of Applied Physiology, vol. 111, no. 6, pp. 1877–1887, 2011. View at Publisher · View at Google Scholar · View at Scopus
  190. J. Wei, W. Yang, S. Yin, C. Wang, Y. Wang, and G. Zheng, “The quality of reporting of randomized controlled trials of electroacupuncture for stroke,” BMC Complementary and Alternative Medicine, vol. 16, article 512, 2016. View at Publisher · View at Google Scholar
  191. W.-H. Lee, C.-Y. Loo, M. Bebawy, F. Luk, R. S. Mason, and R. Rohanizadeh, “Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century,” Current Neuropharmacology, vol. 11, no. 4, pp. 338–378, 2013. View at Publisher · View at Google Scholar · View at Scopus
  192. K. Sakano and S. Kawanishi, “Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes,” Archives of Biochemistry and Biophysics, vol. 405, no. 2, pp. 223–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  193. H. Fang, P.-F. Wang, Y. Zhou, Y.-C. Wang, and Q.-W. Yang, “Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury,” Journal of Neuroinflammation, vol. 10, article 27, 2013. View at Publisher · View at Google Scholar · View at Scopus